Liyen KatrinaKan, ...MasturaMonif, inJournal of Neuroimmunology, 2019 Abstract Gliomasare the most prevalent tumours of thecentral nervous systemand present with high morbidity and mortality. The most common and most aggressive form of glioma isglioblastomamultiforme, of which patients have a median...
Published on behalf of The British Society for Antimicrobial Chemotherapy Impact factor: 5.439 5-Yr impact factor: 4.946 Editor-in-Chief Prof Alan P. Jo... Federico,Pea,Loris,... - 《Journal of Antimicrobial Chemotherapy》 被引量: 151发表: 2003年 Teicoplanin therapy for MRSA bacteraemia: a ...
Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Subscribe to the JAMA Neurology journal full text icon Full Text contents icon Contents figure icon Figures / Tables multimedia icon Multimedia attach icon Supplemental Content references ico...
mt is a cross-disciplinary biomedical journal devoted to publishing the most exciting advances in pharmacology and therapeutics, as they pertain to advances in translational and clinical medicine. It is recognized as one of the most prestigious journals in the field. With an impact factor of 6.825...
Minghua WuKey Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan 410008, ChinaPeifang WeiLippincott Williams & WilkinsChinese Medical Journal
Journal of Hematology & Oncology volume 17, Article number: 31 (2024) Cite this article 5355 Accesses 4 Citations 20 Altmetric Metrics details Abstract Glioblastoma (GBM), the predominant and primary malignant intracranial tumor, poses a formidable challenge due to its immunosuppressive microenvironment...
Glioma is the most common malignant tumor in central nervous system, with significant health burdens to patients. Due to the intrinsic characteristics of glioma and the lack of breakthroughs in treatment modalities, the prognosis for most patients remain
Benson, V. S., Kirichek, O., Beral, V. & Green, J. Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis.International journal of cancer136, 2369–2377, (2017). (2012).
A major rate-limiting step in developing more effective immunotherapies for GBM is our inadequate understanding of the cellular complexity and the molecular heterogeneity of immune infiltrates in gliomas. Here, we report an integrated analysis of 201,986
Glioma is the most common and fatal tumor of the central nervous system in humans. Despite advances in surgery, radiotherapy, and chemotherapeutic agents, glioma still has a poor prognosis. The tumor microenvironment (TME) of glioma is of highly complex